D-0219-2025 Class II Ongoing

Recalled by SKY PACKAGING — Memphis, TN

FDA drug recall D-0219-2025 was initiated by SKY PACKAGING on Jan 24, 2025 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Feb 12, 2025
Initiation Date
Jan 24, 2025
Voluntary/Mandated
Voluntary: Firm initiated

Product description

HydrALAZINE Hydrochloride, 25 mg, 100 Unit Dose Tablets (10x10), USP, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-327-10

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide within the United States

Code information

Lot #: 0000127312, Exp. Date 31-Mar-2025; 0000127576, 0000127577, Exp. Date 31-Jul-2025; 0000128204, Exp. Date 31-Dec-2025; 0000128358, Exp. Date 31-Jan-2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0219-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0219-2025. Report a data issue: hello@regdatalab.com.